At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
KTP-001drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Open-Label, Non-controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of KTP-001 in Subjects With Lumbar Disc Herniation
In Brief
A Phase 2 clinical trial evaluating KTP-001 for Lumbar Disc Herniation. Completed, enrolled 24 participants across 10 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and exploratory efficacy of KTP-001 in subjects with lumbar disc herniation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLumbar Disc Herniation
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2013
First PostedNov 2013
Primary CompletionOct 2018
TodayJul 2026
First PostedNov 8, 2013
Enrollment StartFeb 1, 2013
Primary CompletionOct 16, 2018
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 12.7 years ago
Interventions
KTP-001drug
KTP-001 is one time dose intradiscally.